Application Sponsors
ANDA 208696 | JIANGSU HANSOH PHARM | |
Marketing Status
None (Tentative Approval) | 001 |
None (Tentative Approval) | 002 |
Application Products
001 | POWDER;INTRAVENOUS | EQ 100MG BASE/VIAL | 0 | PEMETREXED | PEMETREXED |
002 | POWDER;INTRAVENOUS | EQ 500MG BASE/VIAL | 0 | PEMETREXED | PEMETREXED |
FDA Submissions
UNKNOWN; | ORIG | 1 | TA | 2018-12-28 | STANDARD |
Submissions Property Types
TE Codes
001 | Prescription | AP |
002 | Prescription | AP |
CDER Filings
JIANGSU HANSOH PHARM
cder:Array
(
[0] => Array
(
[ApplNo] => 208696
[companyName] => JIANGSU HANSOH PHARM
[docInserts] => ["",""]
[products] => [{"drugName":"PEMETREXED","activeIngredients":"PEMETREXED","strength":"EQ 100MG BASE\/VIAL","dosageForm":"POWDER;INTRAVENOUS","marketingStatus":"None (Tentative Approval)","te":"None","rld":"No","rs":"No"},{"drugName":"PEMETREXED","activeIngredients":"PEMETREXED","strength":"EQ 500MG BASE\/VIAL","dosageForm":"POWDER;INTRAVENOUS","marketingStatus":"None (Tentative Approval)","te":"None","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"12\/28\/2018","submission":"ORIG-1","actionType":"Tentative Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
[supplements] =>
[actionDate] => 2018-12-28
)
)